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Abstract Voltage-gated K+ (Kv) channels are particularly
important in the physiology of excitable cells in the heart and
the brain. PSD-95 is known to cluster Shaker channels and
NMDA receptors and the latter is known to couple through K-
actinin-2 to the post-synaptic cytoskeleton [Wyszynski et al.
(1997) Nature 385, 439^442], but the mechanisms by which Kv
channels are linked to the actin cytoskeleton and clustered at
specific sites in the heart are unknown. Here we provide evidence
that Kv1.5 channels, widely expressed in the cardiovascular
system, bind with K-actinin-2. Human Kv1.5 interacts via its
N-terminus/core region and can be immunoprecipitated with
K-actinin-2 both after in vitro translation and from HEK cells
expressing both proteins. The ion channels and K-actinin-2 co-
localize at the membrane in HEK cells, where disruption of the
actin cytoskeleton and antisense constructs to K-actinin-2
modulate the ion and gating current density.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
In the last decade, the role of the cytoskeleton in anchoring
ion channels to regions of the membrane has been closely
examined. Immunohistological studies have shown that ion
channels undergo highly specialized subcellular localization
at the plasma membrane which is crucial to cell function
[2,3]. Shaker-type K channels and NR2 subunits of the
NMDA receptor cluster in neurons through direct linkage
to a core protein of the post-synaptic density, PSD-95 [4,5],
which belongs to a family of membrane-associated guanylate
kinases. These homomultimerize through N-terminus linkages
[6,7] and can cluster K channels into plaque-like formations
at the membrane (PSD-95) or intracellular aggregates
(SAP97) [8,9]. Within PSD-95, repeat regions called PDZ do-
mains facilitate ion channel localization via the distal C-ter-
mini motifs D/E-S/T-X-V of both Shaker and NMDA chan-
nels [10^13].
There is also indirect evidence that cardiac ion channels can
be regulated by cytoskeletal interactions. Muscle Na chan-
nels interact with syntrophins found in the sarcolemma and
the neuro-muscular junction [14]. Syntrophins contain a PDZ
domain [14] and bind dystrophin, which couples them to the
actin cytoskeleton. Na channel gating is directly a¡ected by
cytochalasin treatment in cardiac myocytes [15,16], which al-
ters both channel availability and open probability. Cytocha-
lasins accelerate cardiac ATP-sensitive K channel rundown
[17], attenuate sulfonylurea inhibition [18,19] and directly in-
£uence cardiac KIR recti¢cation and substrate expression [20].
In addition, KvL1 subunit actions on Kv1 (voltage-gated K)
channels are modi¢ed by cytochalasins [21,22]. In this study,
we show that the expression of human Kv1.5 channels in
HEK cells is regulated by cytoskeletal interactions. We further
demonstrate that in HEK cells the channel binds with K-acti-
nin-2, a likely mediator of this regulation. Both disruption of
the actin cytoskeleton with cytochalasin D and incubation
with an K-actinin-2 antisense oligonucleotide signi¢cantly in-
crease Kv1.5-dependent K currents in Kv1.5-expressing
HEK cells. Imaging experiments demonstrate cellular co-lo-
calization of Kv1.5 and K-actinin-2 which is eliminated in the
presence of cytochalasin D. Finally, we show that the K-acti-
nin-2 binding site of Kv1.5 lies in its N-terminus/core region.
These results suggest a role for the actin cytoskeleton and
K-actinin-2 in the organization of K channels at the cell
surface.
2. Materials and methods
2.1. Yeast two-hybrid library screen
A large fragment of Kv1.5 (amino acids (AA) 71^561) was sub-
cloned in frame into the GAL4 DNA binding domain (BD) vector
pGBD-C2 [23] and used to screen a pGAD10 human cardiac cDNA
library (Clontech). Transformants in yeast strain PJ69-4a [23] were
grown on minimal media lacking leucine and tryptophan. After
3 days growth, they were replica-plated to media lacking adenine
and histidine to screen for interaction. Potential interactors were sub-
jected to plasmid loss/retransformation tests to ensure that the resul-
tant phenotype and reporter gene activity was plasmid-dependent.
They were also tested for interaction with empty pGBD-C2 to elim-
inate artifactual interactions.
2.2. Analysis of protein^protein interactions by the yeast two-hybrid
system
Protein^protein interactions were analyzed in two yeast strains.
Growth on media lacking adenine and histidine was monitored in
PJ69-4a harboring the K-actinin-2 clone isolated in the original screen.
L-Galactosidase assays [24] were conducted in Y187. L-gal activity
was measured spectrophotometrically at OD420 where OD = optical
density. Units are: 1 L-gal unit = 1000UOD420/[OD600Utime (h)U
volume of initial culture (ml)]. The following fragments of Kv1.5 were
tested for interaction with K-actinin-2: Kv1.5 (AA 71^561), N-term
(AA 1^209), N-del (AA 210^581), L-N-term (AA 71^361), S4-C-term
(AA 419^561), C-term (AA 515^561) and full C-term (AA 451^614).
All assays were performed on two to three di¡erent yeast transform-
ants on several di¡erent experimental days.
2.3. Cloning and sequencing of the full-length K-actinin-2 gene
From the published sequence of K-actinin-2 in skeletal muscle and
heart [23], primers for the 5P and 3P untranslated regions were de-
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 5 2 1 - 0
*Corresponding author. Fax: (1)-604-822 6048.
E-mail: fedida@interchange.ubc.ca
FEBS 23654 8-5-00 Cyaan Magenta Geel Zwart
FEBS 23654FEBS Letters 473 (2000) 188^194
signed and used to clone K-actinin-2 from human cardiac polyA+
mRNA (Clontech). KpnI and EcoRI sites were engineered into the
primers to facilitate subcloning.
2.4. Antisense experiments
Phosphorothioate oligonucleotides were synthesized by Operon
Technologies (Alameda, CA, USA). The sequence of the K-actinin-2
antisense oligonucleotide, spanning the start codon, was CGT-
GTTCATGGCGCT. The K-actinin-2 sense construct sequence was
AGCGCCATGAACCAG. HEK cells were incubated with 5 WM oli-
gonucleotide for varying time periods and then subjected to electro-
physiological analysis [25]. In some experiments co-transfection with
the vector pHook-1 (Invitrogen, San Diego, CA, USA) and lipofect-
amine was used [26]. This allowed e⁄cient detection of transfected
cells with beads coated with phOX. An K-actinin-2 antisense con-
struct, produced by subcloning the 377 bp KpnI^HindIII fragment
of K-actinin-2 into HindIII^KpnI-digested pcDNA3 was used in
some experiments. Expression from the plasmid produces an antisense
transcript spanning 309 bp of coding sequence, including the start
codon, as well as 68 bp of untranslated leader.
2.5. In vitro translation
In vitro translation was carried out using the Single Tube Protein
System 3, T7 (Novagen). Kv1.5 was translated from pRC/CMV/
Kv1.5. K-Actinin-2 was translated from the full-length clone. Kv1.5
translation reactions included [35S]methionine and were supplemented
with canine pancreatic microsomes (Boehringer Mannheim).
2.6. Co-immunoprecipitations
For in vitro translations, 30 Wl aliquots of in vitro-translated pro-
teins were mixed and then 5 Wl of the anti-K-actinin-2 antibody (Sigma
A5044) was added. The mixtures were held on ice for 2 h and pre-
cipitated by the addition of 20 Wl of pre-swelled protein A-Sepharose
(Sigma). The beads were spun down and washed six times with ex-
traction bu¡er (2 mM Tris^Cl, pH 8.0, 140 mM NaCl, 0.5% Triton X-
100). Bound proteins were extracted by boiling in sodium dodecyl
sulfate (SDS)-sample bu¡er for 5 min and were resolved by poly-
acrylamide gel electrophoresis (PAGE). The resultant gels were dried
and autoradiographed. For co-immunoprecipitations from Kv1.5 and
K-actinin-2 expressing HEK cells, supernatants from cell extracts [27]
were employed as follows. Twenty Wl of pre-swelled Sepharose CL4B
in Bead Bu¡er (20 mM HEPES, pH 7.4, 5% glycerol, 100 mM NaCl,
0.1 mM EDTA) was added to 50 Wl aliquots of the supernatant and
incubated with mixing for 15 min on ice. The mixtures were spun for
15 s in a microcentrifuge and the supernatants transferred to fresh
tubes. Ten Wl of the appropriate antibody (bu¡er in control) was
added to each tube and incubated on ice for 1 h with mixing.
12.5 Wl pre-swelled protein A-Sepharose in Bead Bu¡er was added
to each tube and incubated on ice for 1 h with mixing. The mixtures
were spun for 15 s in the microcentrifuge and the pelleted beads were
then washed three times each with wash bu¡er (10 mM Tris^HCl,
140 mM NaCl, 0.1% Triton X-100, 0.1% hemoglobin, 1 mM
PMSF) then twice with TS bu¡er (10 mM Tris^HCl, 140 mM
NaCl). The pellets were then each boiled in 20 Wl SDS-loading bu¡er
(0.7% Tris base, 13% glycerol, 4.9% L-mercaptoethanol, 2.3% SDS,
0.003% bromophenol blue) and subjected to PAGE. After the gels
were run, they were transferred to PVDF membranes and probed as
Western blots with anti-K-actinin-2 (1:300 dilution) or anti-Kv1.5
(1:250) dilution (Alomone Labs).
2.7. Mammalian cell lines
The human embryonic kidney cell line 293 (HEK-293) was used as
a stable and transient expression system [28]. Cells were grown in
Minimal Essential Medium at 37‡C in an air/5% CO2 incubator.
One day before electrophysiological use, or transfection, cells were
plated on glass coverslips in 25 mm Petri dishes with 30^50% con£u-
ence. All cell culture supplies were obtained from Canadian Life Tech-
nologies (Bramalea, Ont., Canada).
2.8. Electrophysiology
Solutions and methodology for the recording of ion and gating
currents from the stable Kv1.5 cell lines are as previously reported
from our laboratory [26,29]. The standard pipette ¢lling solution con-
tained (in mM): KCl, 135; EGTA, 5; MgCl2, 1; HEPES, 10; and was
adjusted to pH 7.2 with KOH. The standard bath solution contained
(in mM): HEPES, 10; MgCl2, 1; CaCl2, 1; KCl, 5; NaCl, 135; and
was adjusted to pH 7.4 with NaOH. All chemicals were from Sigma
Aldrich (Mississauga, Ont., Canada). For gating currents a W472F
non-conducting mutant channel was used and KCl and NaCl in the
bath and pipette solutions were substituted by NMDG-Cl [29]. Cover-
slips containing cells were removed from the incubator before experi-
ments and placed in a superfusion chamber (volume 250 Wl) contain-
ing the control bath solution at 22^23‡C. Whole-cell recordings were
made using an Axopatch 200B ampli¢er (Axon Instruments, Foster
City, CA, USA). Activation of Kv1.5 was measured on repolarization
to 340 mV after 100 ms depolarizations to between 380 and +80 mV.
Inactivation was measured at +60 mV after 7.5 s conditioning pulses
to between 380 and +50 mV to inactivate currents. Currents were
normalized to peak currents obtained at full activation and without
inactivation. Data were ¢t to a Boltzmann function (y = 1/(1+
exp[(V3V1=2)/k])+C) where V1=2 represents the voltage at which
50% activation or inactivation occurred, V is the membrane potential
and k is the slope factor that re£ects the steepness of the voltage-
dependence. Lines through data points were generated with averaged
parameters obtained from individual data sets.
2.9. Imaging
HEK cells were ¢xed in 2% paraformaldehyde for 10 min. The
¢xation was quenched with 100 mM glycine and the cells were per-
meabilized with 0.1% Triton X-100 for 10 min, rinsed 3U10 min in
phosphate bu¡ered saline and labeled for 24 h at 4‡C with antibodies
speci¢c for Kv1.5 (a⁄nity-puri¢ed polyclonal rabbit anti-rat IgG,
Upstate Biotechnology) and K-actinin (monoclonal IgM, Sigma
A5044). Secondary antibodies were Texas-red conjugated goat anti-
mouse IgM W-chain speci¢c and £uorescein conjugated goat anti-rab-
bit (Jackson Immunobiologicals). A Nikon Diaphot 200 microscope
equipped for epi£uorescence with a 100/1.3 Fluor objective was used
to acquire a series of 2D images through the cell at 0.25 Wm intervals
onto a thermoelectrically-cooled CCD camera (Tektronix TK512CB
chip). Images were dark-current and background subtracted, cor-
rected for non-uniformities across the ¢eld of view and deconvolved
with an empirically determined point-spread-function using the Car-
rington algorithm on an EPR server (Scanalytics) [30]. Small beads
which £uoresced in both wavelengths were added to the coverslips and
used to align the 3D data sets. The voxels corresponding to the most
likely location of the cell surface were identi¢ed utilizing an algorithm
that seeks voxels which are local maxima along an intensity gradient
created by convolving the deconvolved image with a small Gaussian
point spread function (FWHM 4 pixels) [31]. The surface voxel in the
deconvolved image and three voxels on either side, were retained for
analysis, all other voxels were set to an intensity of 0.
3. Results and discussion
3.1. The yeast two-hybrid screen detects a strong interaction
between Kv1.5 and K-actinin-2
An improved version [23] of the yeast two-hybrid system
[32] was used to screen for protein^protein interactions with
the human voltage-gated cardiac Kv channel, Kv1.5. A large
fragment of Kv1.5 (AA 71^561) was subcloned in frame into a
plasmid containing the DNA BD of the GAL4 protein
(pGBD). This fusion protein vector, p1.5GBD was used to
screen a human cardiac cDNA library (Clontech) in the
GAL4 activation domain (AD) plasmid, pGAD10 in yeast
strain PJ69-4A [23]. Several colonies grew on plates lacking
adenine and histidine (3ade,3his), indicating activation of the
reporter genes in PJ69-4A. These were subjected to plasmid
loss/retransformation tests to ensure that the resultant pheno-
type and reporter gene activity were plasmid-dependent. Con-
trol transformations with either empty pGAD, pGBD-C2 or
both, did not grow on the selective medium.
From one colony satisfying these conditions, we isolated a
DNA fragment approximately 2.5 kb in length from the li-
brary plasmid. Sequencing revealed a partial (V30%) coding
region of K-actinin-2 expressed in this clone (pactGAD). The
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sequence encoded AA 583 through 694 of K-actinin-2, repre-
senting roughly half of the third spectrin repeat, the entire
fourth spectrin repeat and the Ca2-binding EF-hands [33].
The incubation of yeast containing p1.5GBD and pactGAD
on reporter gene selective media plates (3ade,3his) at 30‡C
showed signi¢cant growth over a period of 5 days (Fig.
1A).
This ¢nding immediately suggested other yeast two-hybrid
studies that have identi¢ed K-actinin-2 as a PSD protein in rat
brain, directly binding to the C-terminus of both the NR1 and
NR2B subunits of the NMDA receptor through its central
domain spectrin repeats and immunoprecipitating with chan-
nels and PSD-95 [1]. In cultured neurons, K-actinin-2 also co-
localizes with NMDA receptors at the PSD of glutamatergic
synapses [34]. To further isolate the region of Kv1.5 that
interacted with K-actinin-2, we subcloned a number of
Kv1.5 constructs encoding N- and C-terminus regions of the
subunit into pGBD (Fig. 1B). Of these, only N-terminus con-
structs grew on 3ade,3his plates (Fig. 1A, see below) and
signi¢cantly, the N-term construct co-expressed with K-acti-
nin-2 in PJ69-4A papillated on 3ade,3his media (not shown).
Numerous fast-growing colonies appeared on a very slow-
growing background. The growth of these papillae was plas-
mid-dependent and retransformation after plasmid loss re-
turned the papillating phenotype. One explanation for this
phenomenon is that the interaction requires an excess of
one of the interactors. Perhaps K-actinin-2 interacts with a
site that bridges two or more interacting Kv1.5 subunits, or
perhaps the Kv1.5 N-terminus/GAL4 DNA BD fusions are
not e⁄ciently translocated to the yeast nucleus.
3.2. Identi¢cation of Kv1.5 fragments that interact with
K-actinin-2
We targeted the C- and N-termini of Kv1.5 as potential
interacting domains because of previous work with the C-ter-
minus of NMDA channels and due to the hydrophilic and
cytoplasmic nature of both termini in Shaker-type channels.
The N-terminus of Kv1.5 is a large domain of approximately
210 AA and involved in channel assembly, L-subunit-binding
and interaction with other cytoplasmic signaling proteins
[35,36]. The C-terminus is shorter, approximately 100 AA in
length and is a putative target for cytoskeletal proteins and
regulatory kinases. We utilized the yeast two-hybrid lacZ re-
porter gene to estimate the relative strength of interaction
between various domains in Kv1.5 and the K-actinin-2 inter-
acting fragment. Several new Kv1.5/pGBD constructs were
made and co-transformed with pactGAD into yeast contain-
ing a GAL1-lacZ reporter gene. The yeast strain Y187 was
used in place of PJ69-4A, because the latter strain gave con-
stitutive L-galactosidase activity in our hands. Seven di¡erent
regions of Kv1.5 were analyzed (Fig. 1B).
The Kv1.5/GAL4 fusion construct that demonstrated
strong growth in the ADE2/HIS3 reporter gene assay, also
showed high levels of L-galactosidase activity. L-galactosidase
activity of Kv1.5 in pGBD (Fig. 1C), in the presence of pact-
GAD was 15.52 þ 1.18 L-gal units (n = 8); control activity was
1.61 þ 0.14 L-gal units (n = 7). The N-terminus of Kv1.5
(N-term) also yielded signi¢cant L-galactosidase activity
(4.76 þ 0.64, n = 7), but less than the intact Kv1.5, as did a
construct in which the N-terminus of Kv1.5 was deleted
(N-del). L-Galactosidase activity of this construct in the pres-
Fig. 1. Growth and L-galactosidase assays identify the interaction of Kv1.5 channels with an K-actinin-2 fragment. A: Yeast two-hybrid assay
for the interaction of K-actinin-2 (AA 583^694) with Kv1.5 channel fragments. Patches were made as labeled: pGBD (control), p1.5GBD (AA
71^561), pN-delGBD (AA 210^561), pL-N-termGBD (AA 71^361), pS4-C-termGBD, (AA 419^561). All yeast except pGBD contain pactGAD.
Growth on SD3trp,3leu assays for the presence of plasmids carrying the genes. Growth on SD3ade,3his indicates a detectable interaction.
B: Diagrammatic representation of Kv1.5 (top) and fragments of Kv1.5 fused to the GAL4 DNA BD. Black bars denote transmembrane do-
mains 1^6 (left to right). C: L-Galactosidase activity initiated by the interaction of Kv1.5 domains or Kv1.4 C-terminus (Kv1.4-C) subcloned
into pGBD, with K-actinin-2 in pactGAD. Yeast in the control assay contained solely pactGAD. Yeast transformed with any Kv1.5 fragment/
pGBD plasmid alone showed no L-gal activity higher than controls or Kv1.4 C-terminus. n = 6^11 for L-gal constructs. * in (C) indicate a sig-
ni¢cant di¡erence from control, P6 0.05.
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ence of pactGAD was comparable to that of the N-terminus
alone (4.56 þ 0.76, n = 6). A construct across the boundary of
these constructs (L-N-term) reconstituted more of the L-gal
activity of Kv1.5 in pGBD (7.68 þ 1.5, n = 5). Thus, a signi¢-
cant portion of the interaction between Kv1.5 and K-actinin-2
is mediated across a region where the N-terminus meets the
core transmembrane domains of the protein. As evidenced by
the papillation noted for the N-terminus construct, some of
the L-galactosidase activities reported here probably re£ect the
background levels of interaction and may underestimate in-
teraction strengths in vivo.
Three C-terminus fragments of Kv1.5 were examined for
interaction with K-actinin-2. None yielded lacZ reporter
gene activity above control, showing that there is little to no
interaction between the C-terminus of Kv1.5 and K-actinin-2.
To con¢rm previous studies that excluded this region as bind-
ing K-actinin-2 [1], an additional vector was constructed, fus-
ing the C-terminus of Shaker-type Kv1.4 (Kv1.4-C, AA 611^
654) to the GAL4 BD. L-Galactosidase activity for the Kv1.4
C-terminus was not signi¢cantly di¡erent from control at
1.78 þ 0.28, n = 15. The site of interaction of K-actinin-2 ap-
pears to be near the boundary of the N-terminus with the ¢rst
transmembrane domain of Kv1.5 (Fig. 1). This di¡erentiates it
from NMDA receptor/K-actinin-2 interaction and that of
Shaker channels with other cytoskeletal proteins which are
mediated through their C-termini.
3.3. Co-immunoprecipitation of K-actinin-2 and Kv1.5
After cloning and sequencing of K-actinin-2, we in vitro-
translated both the full-length Kv1.5 and K-actinin-2 in rabbit
reticulocyte lysate. This experiment allowed a test of direct
interactions between the two proteins without the possible
intercession of other proteins present in co-immunoprecipita-
tions from cells or tissues. Kv1.5 was translated in the pres-
ence of [35S]methionine and canine pancreatic microsomes and
immunoprecipitated with unlabeled in vitro-translated K-acti-
nin-2 using the anti-K-actinin antibody. When bound to pro-
tein A-Sepharose, the antibody precipitated [35S]Kv1.5 (Fig.
2A, lane 1) when K-actinin-2 was present. Kv1.5 was not
pulled down in the absence of K-actinin-2 (lane 2) or antibody
(lane 3). This in vitro experiment has been fully con¢rmed in
HEK cells. Using a new antibody to Kv1.5 (Transduction
Labs) which detects a single band in Kv1.5-transfected HEK
cells (not shown), K-actinin-2 can be e⁄ciently co-immuno-
precipitated with Kv1.5 from the HEK cell extracts (Fig.
2B,C, lane 3). Antibody to K-actinin-2 also e⁄ciently pulls
down Kv1.5 with K-actinin-2 (Fig. 2B,C, lane 2). These are
detected at V98 kDa when the Western blot was probed with
the anti-K-actinin-2 antibody (Fig. 2B) and atV68 kDa when
the Western blot was probed with anti-Kv1.5 (Fig. 2C). The
controls in lane 1 of Fig. 2B,C exclude non-speci¢c actinin-2-
or Kv1.5-binding to the protein A-Sepharose. These results
con¢rm the interaction between Kv1.5 and K-actinin-2 seen
in the yeast two-hybrid growth assay, both in vitro and in
HEK cells.
3.4. The cytoskeleton and K-actinin-2 are important in Kv
channel function
Studies on the NMDA receptor have shown that actin de-
polymerization reduces channel activity [37]. This led to iden-
ti¢cation of calmodulin, in competition with the actin-binding
protein, K-actinin-2, as a mediator of Ca2-dependent inacti-
vation of NMDA channels [1,38,39]. Using cytochalasin D
and a stable cell line expressing Kv1.5, we examined the func-
tional e¡ects of coupling between the actin cytoskeleton,
K-actinin-2 and Kv1 channels. Exposure to cytochalasin D
for longer than 2 h caused a huge increase in ionic and gating
currents through Kv1.5 channels (Fig. 3). Control ionic cur-
rents from the Kv1.5 stable line are relatively small at 200^300
pA/pF (Fig. 3A); currents in cytochalasin D-treated cells were
over 700 pA/pF at 2 h and over 1000 pA/pF after incubation
for longer than 24 h. A reduced but highly signi¢cant e¡ect
was also shown with the weaker actin depolymerizing agent
cytochalasin B (Fig. 3B). The actions of cytochalasin D were
entirely prevented by pre-incubation with phalloidin (Fig. 3B).
We used gating current measurements to test whether the
observed ionic current increase resulted from an increase in
the number of functional channels at the plasma membrane.
Normally in this cell line the channel density at the cell sur-
face is at the lower limit of recording of gating currents (Fig.
3C). After cyto-D for 48 h gating currents could be clearly
observed and conform well to those we have observed previ-
ously from Kv1.5 [40]. Mean data from 15 cells con¢rmed this
highly signi¢cant action (Fig. 3D). These results con¢rmed
that at least part of the current increase was caused by
more functioning channels at the cell surface, but it did not
Fig. 2. Co-immunoprecipitation of Kv1.5 with K-actinin-2. A: From
in vitro translation reactions. Both reactions were mixed together
and immunoprecipitated using the anti-K-actinin antibody and pre-
cipitated using protein A-Sepharose (lane 1). In lane 2 immunopre-
cipitation is attempted in the absence of K-actinin-2 or in the ab-
sence of the antibody (lane 3). Immune complexes were resolved by
SDS^polyacrylamide gel electrophoresis. B: Co-immunoprecipitation
of K-actinin-2 with Kv1.5. Extracts from K-actinin-2, Kv1.5 double
expressing HEK cells were mixed without antibody (lane 1), anti-K-
actinin-2 (lane 2) or anti-Kv1.5 (lane 3), precipitated with protein
A-Sepharose and subjected to Western analysis. The blot is probed
with anti-K-actinin-2. C: Co-immunoprecipitation of Kv1.5 with
K-actinin-2. The blot is identical to that in (B) except that it was
probed with anti-Kv1.5. Controls (no antibody) lane 3 in (A) and
lane 1 in (B) and (C) exclude non-speci¢c binding of K-actinin-2
and Kv1.5 to the protein A-Sepharose.
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exclude the possibility that further e¡ects occurred on the
single channel open probability. However, we found no action
on whole cell activation or inactivation kinetics in Kv1.5 that
explained such a large current increase or that suggested mod-
i¢cation of current kinetics after disruption of the cytoskele-
ton (Fig. 3E). These cytochalasin data support a potential
linkage between the actin cytoskeleton and Kv1.5 channels
mediated through K-actinin-2.
3.5. K-Actinin-2 antisense oligonucleotide mimics cytochalasins
in its e¡ect
In order to determine whether K-actinin-2 might mediate
the interaction of Kv1.5 with the actin cytoskeleton, we car-
ried out antisense experiments. HEK cells stably expressing
Kv1.5 were incubated with 5 WM phosphorothioate K-acti-
nin-2 antisense oligonucleotide (Fig. 4A). After 2^6 h incuba-
tion with this oligonucleotide, Kv1.5 current density was more
than doubled (P6 0.05), while incubation with K-actinin-2
sense oligonucleotide yielded no changes in Kv1.5 currents.
We also transiently transfected the oligonucleotide, along
with the vector pHook1 (see Section 2) and used beads to
identify transfected cells at 72 h (Fig. 4B). Again, antisense
incubation increased Kv1.5 between two and three times,
whereas the sense oligonucleotide had little e¡ect. Finally,
the stable Kv1.5 cell line was transfected with an K-actinin-2
antisense construct in pcDNA3. This construct had qualita-
tively similar actions on Kv1.5 current to cytochalasins and
antisense oligonucleotide incubation. Forty-eight h after tran-
sient transfection with this construct, Kv1.5 current density
was doubled (P6 0.05, Fig. 4C). Cytochalasins and antisense
to K-actinin-2 both caused an increase in Kv1.5 currents. It is
reasonable to infer that the increase in current seen after anti-
sense administration may result from a disconnection of
Kv1.5 from the actin cytoskeleton, associated with a reduction
of K-actinin-2 in the cell.
3.6. Co-localization of Kv1.5 and K-actinin at the HEK cell
surface
To further examine the functional interaction between
Kv1.5 channels and K-actinin-2, HEK cells stably expressing
Kv1.5 were ¢xed and labeled with antibodies speci¢c for
Kv1.5 and K-actinins. Images of labeled cells were obtained
on a wide-¢eld microscope and deconvolved so that the rela-
tive position of the two proteins could be assessed (Fig. 5). As
the image in Fig. 5A demonstrates, both Kv1.5 and K-actinin
could be seen throughout the cell, but were extensively co-
localized only at the cell periphery (arrow). Peripheral co-lo-
calization was lost following pre-treatment with 5 WM cyto-
chalasin D (Fig. 5B). This was more e¡ectively visualized by
isolating those voxels corresponding to the cell surface (Fig.
5C,D). Treated cells became more rounded and developed
undulations and ru¥ing in the cell surface and whereas 49%
Fig. 3. Cytochalasins greatly enhance Kv channel currents in stably transfected HEK cells. A: E¡ect of 5 WM cytochalasin D on Kv1.5 current
at +40 mV at 72 h. Cell was held at 380 mV and pulsed to +60 mV at 0.2 Hz. B: Mean data for cyto-D and cyto-B action on Kv1.5 (n val-
ues above bar) at di¡erent times from 2 to 72 h. Pre-incubation with 5 WM phalloidin for 5 h prevents 5 WM cyto-D action (at 24 h) on
Kv1.5. * indicates a signi¢cant di¡erence from control, one-way ANOVA, P6 0.05. C: Gating current at +60 mV in control and after 48 h
cyto-D. Cells were held at 380 mV and pulsed for 10 ms, fast transients are capacitance spikes at the start and end of voltage pulses. Data
have been leak subtracted, ¢ltered at 10 kHz and sampled at 50 kHz. D: Mean gating charge increase for 15 cells with cyto-D, * indicates dif-
ference from control, P6 0.05. E: No e¡ect of cyto-D on whole cell activation and inactivation kinetics for Kv1.5, symbols as indicated. Test
pulse currents were normalized to the largest current amplitude, plotted against conditioning pulse potentials. Data are from 4^8 cells.
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of the voxels identi¢ed as containing K-actinin were located at
the surface in control cells, this decreased to 17% following
treatment with cytochalasin D. This re-positioning of K-acti-
nins produced a signi¢cant reduction in the extent of co-local-
ization of Kv1.5 and K-actinin-2, which decreased from 2554
of 3876 voxels (65.9%) before, to 291 of 4121 voxels (7%) after
pre-treating cells with cytochalasin D.
To summarize, we have found an interaction between a
human cardiac K channel and K-actinin-2, that limits the
channel current measured at the HEK cell surface. We suggest
that K-actinin-2 limits channel open probability or in some
other way controls the functional activity or expression of
channels at the cell surface. Certainly, the imaging data indi-
cates more free Kv1.5 at the cell surface in the presence of
cytochalasin D. The two possible interpretations of this ob-
servation are that the cytoskeleton, presumably through
K-actinin-2, limits the density of Kv1.5 at the membrane or
alters the kinetics of channels present there or both. In de¢n-
ing this interaction between Kv channels and the cytoskeleton,
this study points the way to new regulatory mechanisms for
cardiac voltage-gated ion channels, using precedents estab-
lished in neurons. Conceivably, during normal electromechan-
ical activity, cardiac Kv current density may be regulated by
these cytoskeletal connections. By extension from work in
Fig. 5. Kv1.5 and K-actinin-2 co-localization in transfected HEK cells. A: Distribution of Kv1.5 (green) and K-actinin (red) in an HEK cell,
voxels containing both proteins are white, optical section is 500 nm in Z, scale bar = 2.44 Wm. The arrow points to the high degree of co-local-
ization of these proteins at the cell surface. B: After treatment with cytochalasin D for 48 h. The arrow indicates little coincidence at the cell
surface between Kv1.5 and K-actinin. C: The voxels corresponding to the surface of the cell were isolated and a series of 500 nm optical sec-
tions through a HEK cell, labeled as in (A), are displayed. Similar results seen in three other pairs of experiments in control and after exposure
to 5 WM cytochalasin D.
Fig. 4. E¡ect of K-actinin-2 antisense constructs on Kv1.5 currents. A: Kv1.5-transfected HEK cells were incubated for 2 to 6 h in 5 WM anti-
sense or sense oligonucleotides. Mean current densities were obtained from triplicated dishes of control cells incubated in the absence or in the
presence of sense and antisense oligonucleotides. Current density was normalized to control where mean Kv1.5 current density was 262 þ 46
pA/pF. B: As in (A), except that cells were transiently transfected with the oligonucleotides and the vector pHook1 plus lipofectamine. Cells
were assayed for current at 72 h. Control cells (transfected with pHook alone) had a current density of 248 þ 47 pA/pF for antisense data and
396 þ 72 pA/pF for sense experiments. Cells were transfected at 1:1, 10:1 and 100:1 w:w ratios of oligonucleotide to pHook1 plasmid DNA.
C: E¡ects on Kv1.5 ionic current of transient expression of an K-actinin-2 antisense plasmid construct into the Kv1.5 HEK stable cell line.
Mean current densities were obtained from control cells (269 þ 64 pA/pF) and after 48 h transfection with lipofectamine. Transfection with
empty vector had no e¡ect on Kv1.5 currents. Number of cells examined indicated above each bar.
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neurons, the possibility also exists that these Kv channels may
be regulated by Ca2, calmodulin and associated kinases [41].
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